Adam Rosenthal, Star Therapeutics founder and CEO

Stars align as ex-True North team nabs an­oth­er $90M to build out biotech con­stel­la­tion

Star Ther­a­peu­tics, which cre­at­ed two an­ti­body-fo­cused biotech star­tups with more in the works, has now reeled in a $90 mil­lion Se­ries C.

The round, dis­closed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.